Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

allogeneic nicotinamide-expanded natural killer cells

Allogeneic, nicotinamide (NAM)-expanded natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon administration, the allogeneic NAM-expanded NK cells may lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response. Ex-vivo treatment with the vitamin B3 derivative NAM increases the in-vivo homing, retention and proliferation potential of the NK cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic NAM NK cells
allogeneic NAM NKs
donor nicotinamide-expanded natural killer cells
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search